Literature DB >> 6135725

Attenuation of exercise conditioning by low dose beta-adrenergic receptor blockade.

R C Marsh, W R Hiatt, H L Brammell, L D Horwitz.   

Abstract

Because it has been shown that high doses of propranolol (40 to 80 mg orally, four times daily) markedly attenuate cardiovascular response to exercise training in healthy subjects, the effects of lower doses of this nonselective beta-adrenergic receptor antagonist on the conditioning response were investigated. Twelve normal men underwent maximal treadmill testing before and after a 6 week intensive exercise program. After an initial test, six men were randomized in a paired fashion to receive low dose propranolol and the others received no drug. The average propranolol dose +/- standard error was 22 +/- 4 mg four times daily, and the average decrease in maximal heart rate due to propranolol was 32 +/- 4 beats/min. Both groups trained at comparable intensities. At the end of the training period, propranolol was stopped and testing was repeated so that the effect of beta-receptor blockade was no longer present but the training effects still persisted. Maximal oxygen consumption increased in control subjects from 47.5 +/- 1.1 to 51.4 +/- 0.4 ml/kg per min (p less than 0.05) but was unchanged in those receiving propranolol (47.2 +/- 1.9 versus 47.4 +/- 1.5). Exercise duration increased in both groups but the increment was greater in the control group (+2.4 versus +1.1 min, p less than 0.05). It is concluded that low level beta-receptor blockade attenuates cardiovascular conditioning in normal subjects in exercise training programs. High levels of sympathetic stimulation during training appear to be important, if not essential, to the conditioning process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135725     DOI: 10.1016/s0735-1097(83)80284-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.

Authors:  P A Ades; E E Wolfel; W R Hiatt; C Fee; R Rolfs; H L Brammell; L D Horwitz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning.

Authors:  M J Sullivan; P F Binkley; D V Unverferth; J H Ren; H Boudoulas; T M Bashore; A J Merola; C V Leier
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 3.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

4.  Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.

Authors:  P A Ades
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

Review 5.  Exercise performance and beta-blockade.

Authors:  P A Tesch
Journal:  Sports Med       Date:  1985 Nov-Dec       Impact factor: 11.136

6.  Exercise capacity and ventilatory response during exercise in COPD patients with and without β blockade.

Authors:  Wilawan Thirapatarapong; Hilary F Armstrong; Matthew N Bartels
Journal:  Lung       Date:  2013-07-23       Impact factor: 2.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.